HLA studies in moyamoya disease

Moyamoya Disease Update

Volumn , Issue , 2010, Pages 54-59

  Park, Myoung Hee ^a   Hong, Seok Ho ^b   Wang, Kyu Chang ^c  

^a Seoul National University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Seoul National University Children's Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857057201     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-4-431-99703-0_9     Document Type: Chapter

References (20)

1. Kuroda S, Houkin K (2008) Moyamoya disease:current concepts and future perspectives. Lancet Neurol 7:1056-1066
2. Hashitaka H, Liu W, Mineharu Y et al (2008) Current knowledge on the genetic factors involved in moyamoya disease. Brain Nerve 60:1261-1269 (in Japanese)
3. Mineharu Y, Takenaka K, Yamakawa H et al (2006) Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry 77:1025-1029
4. Ikeda H, Sasaki T, Yoshimoto T et al (1999) Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 64:533-537
5. Inoue TK, Ikezaki K, Sasazuki T et al (2000) Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 15:179-182
6. Sakurai K, Horiuchi Y, Ikeda H et al (2004) A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 49:278-281
7. Yamauchi T, Tada M, Houkin K et al (2000) Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 31:930-935
8. Mineharu Y, Liu W, Inoue K et al (2008) Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 70:2357-2363
9. Kitahara T, Okumura K, Semba A et al (1982) Genetic and immunologic analysis on moya-moya. J Neurol Neurosurg Psychiatry 45:1048-1052
10. Aoyagi M, Ogami K, Matsushima Y et al (1995) Human leukocyte antigen in patients with moyamoya disease. Stroke 26:415-417
11. Inoue TK, Ikezaki K, Sasazuki T et al (1997) DNA typing of HLA in the patients with moyamoya disease. Jpn J Hum Genet 42:507-515
12. Inoue TK, Ikezaki K, Sasazuki T et al (1997) Analysis of class II genes of human leukocyte antigen in patients with moyamoya disease. Clin Neurol Neurosurg 99 (Suppl 2):S234-237
13. Han H, Pyo CW, Yoo DS et al (2003) Associations of moyamoya patients with HLA class I and class II alleles in the Korean population. J Korean Med Sci 18:876-880
14. Massey HD, McPherson RA (2007) Human leukocyte antigen: the major histocompatibility complex of man. In: McPherson RA, Pincus AR (eds) Henry's clinical diagnosis and management by laboratory methods, 21st edn. Saunders, Philadelphia
15. Warrens AN, Lechler RI (2000) Mechanisms of HLA and disease associations. In: Lechler R, Sarrens A (eds) HLA in health and disease, 2nd edn. Academic, San Diego
16. Tiwari JL, Terasaki PI (1985) HLA and disease associations. Springer, New York
17. Park MH, Hwang YS, Park KS et al (1998) HLA haplotypes in Koreans based on 107 families. Tissue Antigens 51:347-355
18. Aoyagi M, Fukai N, Yamamoto M et al (1996) Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Stroke 27:1750-1754
19. Shi Y, Patel S, Niculescu R et al (1999) Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. Arterioscler Thromb Vasc Biol 19:1150-1155
20. Kang HS, Kim SK, Cho BK et al (2006) Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery 58:1074-1080